1. Stats
  2. USPTO
  3. TC 1600
  4. Group 1620
  5. Art Unit 1626
  6. Examiner Stockton

Examiner Stockton Laura L

1626-STOCKTON-LAURA-L

Employment Information

Art Unit:1626 — Drug, bio-affecting and body treating compositions
Group:1620 — Biomedicinal Chemistry
Classes: 514 — Drug, bio-affecting and body treating compositions
548 — Organic compounds -- part of the class 532-570 series
544 — Organic compounds -- part of the class 532-570 series
558 — Organic compounds -- part of the class 532-570 series
549 — Organic compounds -- part of the class 532-570 series
546 — Organic compounds -- part of the class 532-570 series
534 — Organic compounds -- part of the class 532-570 series
540 — Organic compounds -- part of the class 532-570 series
504 — Plant protecting and regulating compositions
424 — Drug, bio-affecting and body treating compositions
Phone:(571) 272-0710
Email:laura.stockton@uspto.gov
Location:VA 22314
Title:Pat Examnr Gen Chem
Service:32 years
Grade:GS-14

Grant Rate and Difficulty Ranking

51
3-Year Grant rate: 77% over 597 cases
Difficulty: Medium
Difficulty Percentile: 51st

With Examiner Stockton, you have a 77% chance of getting an issued patent by 3 years after the first office action. Examiner Stockton is a medium examiner and in the 51st percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Stockton, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1626

Examiner Stockton's grant rate is higher than that of Art Unit 1626 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Stockton 1.2
Art Unit 1626 1.1

Interview Benefit

Grant Rate without Interview

Examiner Stockton has granted 412 of 535 cases without any applicant-requested interviews for a grant rate of 77%.

Grant Rate with Interview

Examiner Stockton has granted 49 of 62 cases with at least one applicant-requested interview for a grant rate of 79%.

Interview Benefit

With Examiner Stockton, conducting an interview increases your chance of getting a patent granted by 3%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
18019638 Trpml Modulators Rejection information available with a Premium Stats subscription. See our pricing. Abandoned View
18017197 Scalable Synthetic Route For Psilocin And Psilocybin Patented View
17636729 Pigmented And Fluorescent Compounds Derived From The Addition Of A Primary Or Secondary Amine To An Aldehyde Patented View
18486712 Antagonists Of The Muscarinic Acetylcholine Receptor M4 Patented View
17954986 Organic Compound And Sensor And Sensor Embedded Display Panel And Electronic Device Patented View
17672306 Hemolytic Reagent, Reagent Kit, And Method For Classifying White Blood Cells Patented View
17904726 Cyclic Thioether Compound, Vegetable Oil Composition Containing The Same, Their Preparation And Application Thereof Patented View
17934968 Compounds And Their Use In The Treatment Of Bacterial Infection Abandoned View
17590715 Electrolyte Solution And Method For Producing Sulfate Salt Patented View
18011532 Production Of Dinitriles Patented View
17997456 Benzothiazolyl Biaryl Compound, And Preparation Method And Use Abandoned View
17784298 6-Azido-1.3 Benzo[De]isoquinoline Compounds Photo-Crosslinked By Visible Light And Uses Thereof Patented View
17635891 Inhibitors Of Phospholipid Synthesis And Methods Of Use Patented View
17905202 Dithienophosphorine Compound, And Colorless Near-Infrared Absorbing Material And Electrochromic Material Each Using Same Abandoned View
18459937 Map4k4 Inhibitors Abandoned View
18647107 Antiviral Heterocyclic Compounds Patented View
18592900 P2x3 And/or P2x2/3 Receptor Antagonist, Pharmaceutical Composition Comprising Same, And Use Thereof Patented View
17615123 Thiadiazolyl Derivatives Patented View
18024216 Bicyclic-Heterocycle Derivatives And Their Uses As Orexin-2 Receptor Agonists Patented View
17996544 2-Arylthiazole Derivative Or Salt Thereof, Preparation Method Therefor, And Pharmaceutical Composition Comprising Same Patented View
18597843 Dicarboxylic Acid Diesters Patented View
18195767 Glp-1r Modulating Compounds Patented View
18000444 Beta-Lactam Compound, Use Thereof And Preparation Method Therefor Patented View
17757597 A Compound For The Determination Of The Protein Fkbp12 And A Sensor Unit Comprising It Patented View
18461886 Masp-2 Inhibitors And Methods Of Use Patented View
17777260 Hydro-1h-Pyrrolo[1,2-A]pyrazine Compounds For The Treatment Of Autoimmune Disease Patented View
17775773 Quinoline Compound And Use Thereof Patented View
18332587 Phospholipid Compounds And Uses Thereof Patented View
17998355 Pyridine Derivative And Application Thereof Patented View
17442828 Indole-Ynone Mediated Benzoannulation Process For The Preparation Of Carbazoles, Carbazomycin A, Calothrixin B And Staurosporinone Patented View
18413767 Diacylglycerol Kinase Modulating Compounds Abandoned View
18015767 Amido Cyclohexane Acid Derivatives As Lpa Receptor Inhibitors Patented View
18465497 Diacylglyceride O-Acyltransferase 2 Inhibitors Patented View
17743234 Thiophene Compounds With Cyclic Amides, And Uses Thereof Abandoned View
17795778 Compounds And Uses Thereof Patented View
18666109 Salts And Solid Forms Of (R)-1-(5-Methoxy-1h-Indol-1-Yl)-N,n-Dimethylpropan-2-Amine Patented View
17919483 Gpr52 Modulators And Methods Of Use Patented View
17260622 Probe For Detecting Carbapenem-Resistant Bacteria And Use Thereof Patented View
18142842 Condensed Heterocyclic Derivates As Bcl-2 Inhibitors For The Treatment Of Neoplastic Diseases Patented View
18125961 Inhibitors Of The Wnt/beta-Catenin Pathway Patented View
17791852 Multi-Aziridine Compound Patented View
17438068 Process For The Preparation Of Eliglustat And Its Intermediate Patented View
17254517 Metabolically Stable Prodrugs Patented View
17815064 Method For Producing Difluoromethyl-Substituted Aromatic Heterocyclic Compound Patented View
17786593 Phosphate Derivatives Of Rorgamma Modulators And Uses Thereof Patented View
17614067 Imidazopyridine Derivatives As Il-17 Modulators Patented View
18437502 Quinoline Compounds As Inhibitors Of Kras Patented View
17312308 Synthesis Of (S)-6-Hydroxytryptophan And Derivatives Thereof Patented View
18526983 Modulators Of Eukaryotic Initiation Factor 2 Abandoned View
17427778 Pharmaceutical Composition For Treating Or Preventing Middle East Respiratory Syndrome Abandoned View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.